20240219 lab meeting_俐妤 | 賴亮全實驗室

索引

00:00 1.
index 1
00:21 2.
Metabolic heterogeneity in lung tumors
01:08 3.
LncRNA ADPGK-AS1 was upregulated in TAMs
04:10 4.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
04:12 5.
LncRNA ADPGK-AS1 was upregulated in TAMs
05:40 6.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
11:50 7.
MRPL35 was abundant in M2-like TAMs
18:52 8.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
23:32 9.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:12 10.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:13 11.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
25:13 12.
ADPGK-AS1 overexpression decreased ROS levels
25:14 13.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:14 14.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:15 15.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
25:15 16.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
25:16 17.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 18.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 19.
ADPGK-AS1 influenced human lung tumor progression ex vivo
25:17 20.
CircZFR modulated MYO1B splicing
25:17 21.
Slide 19
25:17 22.
Thank you for listening
25:18 23.
RNA therapy
25:18 24.
Oxygen consumption rate (OCR)
28:58 25.
RNA therapy
28:59 26.
Thank you for listening
28:59 27.
Slide 19
28:59 28.
CircZFR modulated MYO1B splicing
29:00 29.
ADPGK-AS1 influenced human lung tumor progression ex vivo
29:00 30.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 31.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 32.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
29:02 33.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
29:03 34.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:03 35.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:04 36.
ADPGK-AS1 overexpression decreased ROS levels
29:05 37.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
29:05 38.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:06 39.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:08 40.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
30:20 41.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
36:55 42.
ADPGK-AS1 overexpression decreased ROS levels
38:57 43.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
39:00 44.
ADPGK-AS1 overexpression decreased ROS levels
39:07 45.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:32 46.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:37 47.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:38 48.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
45:33 49.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
49:03 50.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:11 51.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:13 52.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:14 53.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
50:33 54.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:33 55.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:34 56.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:35 57.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
51:09 58.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
51:10 59.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:37 60.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:41 61.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
58:29 62.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
1:01:25 63.
ADPGK-AS1 influenced human lung tumor progression ex vivo
1:04:03 64.
CircZFR modulated MYO1B splicing
1:04:16 65.
Slide 19
1:06:32 66.
Thank you for listening
1:06:42 67.
** after 20240219 lab meeting_俐妤.pptx

筆記 (0)

未登入或權限不足!

討論

00:00 1.
index 1
00:21 2.
Metabolic heterogeneity in lung tumors
01:08 3.
LncRNA ADPGK-AS1 was upregulated in TAMs
04:10 4.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
04:12 5.
LncRNA ADPGK-AS1 was upregulated in TAMs
05:40 6.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
11:50 7.
MRPL35 was abundant in M2-like TAMs
18:52 8.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
23:32 9.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:12 10.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:13 11.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
25:13 12.
ADPGK-AS1 overexpression decreased ROS levels
25:14 13.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:14 14.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:15 15.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
25:15 16.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
25:16 17.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 18.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 19.
ADPGK-AS1 influenced human lung tumor progression ex vivo
25:17 20.
CircZFR modulated MYO1B splicing
25:17 21.
Slide 19
25:17 22.
Thank you for listening
25:18 23.
RNA therapy
25:18 24.
Oxygen consumption rate (OCR)
28:58 25.
RNA therapy
28:59 26.
Thank you for listening
28:59 27.
Slide 19
28:59 28.
CircZFR modulated MYO1B splicing
29:00 29.
ADPGK-AS1 influenced human lung tumor progression ex vivo
29:00 30.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 31.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 32.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
29:02 33.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
29:03 34.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:03 35.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:04 36.
ADPGK-AS1 overexpression decreased ROS levels
29:05 37.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
29:05 38.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:06 39.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:08 40.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
30:20 41.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
36:55 42.
ADPGK-AS1 overexpression decreased ROS levels
38:57 43.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
39:00 44.
ADPGK-AS1 overexpression decreased ROS levels
39:07 45.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:32 46.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:37 47.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:38 48.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
45:33 49.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
49:03 50.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:11 51.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:13 52.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:14 53.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
50:33 54.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:33 55.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:34 56.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:35 57.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
51:09 58.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
51:10 59.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:37 60.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:41 61.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
58:29 62.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
1:01:25 63.
ADPGK-AS1 influenced human lung tumor progression ex vivo
1:04:03 64.
CircZFR modulated MYO1B splicing
1:04:16 65.
Slide 19
1:06:32 66.
Thank you for listening
1:06:42 67.
** after 20240219 lab meeting_俐妤.pptx

分享
- 嵌入網址
- QR code

索引
筆記
討論
全螢幕

20240219 lab meeting_俐妤

長度: 1:06:51, 瀏覽: 57, 最近修訂: 2024-02-19

00:00 1.
index 1
00:21 2.
Metabolic heterogeneity in lung tumors
01:08 3.
LncRNA ADPGK-AS1 was upregulated in TAMs
04:10 4.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
04:12 5.
LncRNA ADPGK-AS1 was upregulated in TAMs
05:40 6.
LncRNA ADPGK-AS1 was upregulated in TAMs in association with mitochondria
11:50 7.
MRPL35 was abundant in M2-like TAMs
18:52 8.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
23:32 9.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:12 10.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
25:13 11.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
25:13 12.
ADPGK-AS1 overexpression decreased ROS levels
25:14 13.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:14 14.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
25:15 15.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
25:15 16.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
25:16 17.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 18.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
25:16 19.
ADPGK-AS1 influenced human lung tumor progression ex vivo
25:17 20.
CircZFR modulated MYO1B splicing
25:17 21.
Slide 19
25:17 22.
Thank you for listening
25:18 23.
RNA therapy
25:18 24.
Oxygen consumption rate (OCR)
28:58 25.
RNA therapy
28:59 26.
Thank you for listening
28:59 27.
Slide 19
28:59 28.
CircZFR modulated MYO1B splicing
29:00 29.
ADPGK-AS1 influenced human lung tumor progression ex vivo
29:00 30.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 31.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
29:01 32.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
29:02 33.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
29:03 34.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:03 35.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
29:04 36.
ADPGK-AS1 overexpression decreased ROS levels
29:05 37.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
29:05 38.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:06 39.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
29:08 40.
ADPGK-AS1 overexpression altered the regulation of mitochondrial metabolism
30:20 41.
ADPGK-AS1 overexpression increased levels of TCA cycle metabolites
36:55 42.
ADPGK-AS1 overexpression decreased ROS levels
38:57 43.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
39:00 44.
ADPGK-AS1 overexpression decreased ROS levels
39:07 45.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:32 46.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:37 47.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
41:38 48.
Macrophages upregulated ADPGK-AS1 and adapted their metabolic signaling pathways after crosstalk with tumor cells
45:33 49.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
49:03 50.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:11 51.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:13 52.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:14 53.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
50:33 54.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:33 55.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
50:34 56.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
50:35 57.
ADPGK-AS1 overexpression in macrophages induced a tumor-promoting M2-like phenotype
51:09 58.
ADPGK-AS1 knockdown in macrophages induced M1-like phenotype
51:10 59.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:37 60.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
57:41 61.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
58:29 62.
ADPGK-AS1 knockdown inhibited tumor growth in vivo
1:01:25 63.
ADPGK-AS1 influenced human lung tumor progression ex vivo
1:04:03 64.
CircZFR modulated MYO1B splicing
1:04:16 65.
Slide 19
1:06:32 66.
Thank you for listening
1:06:42 67.
** after 20240219 lab meeting_俐妤.pptx

位置

資料夾名稱

2024

發表人

朱庭汶

單位

賴亮全教授

建立

2024-02-19 10:22:21

最近修訂

2024-02-19 10:46:12

長度

1:06:51